NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-28

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 32

Registration Number: NCT00000865

Locations: 🇺🇸
UCSD Maternal, Child, and Adolescent HIV CRS, San Diego, California, United States
🇺🇸
Usc La Nichd Crs, Los Angeles, California, United States
🇺🇸
Tulane/LSU Maternal/Child CRS, New Orleans, Louisiana, United States

and more 4 locations

Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-28

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 10

Registration Number: NCT00000734

Locations: 🇺🇸
Univ of Pittsburgh Med School, Pittsburgh, Pennsylvania, United States

Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

Phase 1

Withdrawn

Conditions: HIV Infections
HIV Seronegativity

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00000809

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Phase 2

Completed

Conditions: HIV Infections
Hodgkin's Disease

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 27

Registration Number: NCT00000626

Locations: 🇺🇸
St. Louis ConnectCare, Infectious Diseases Clinic, Saint Louis, Missouri, United States
🇺🇸
SUNY - Buffalo, Erie County Medical Ctr., Buffalo, New York, United States
🇺🇸
The Ohio State Univ. AIDS CRS, Columbus, Ohio, United States

and more 5 locations

A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00000792

Locations: 🇺🇸
Beth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States
🇺🇸
Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
🇺🇸
NY Univ. HIV/AIDS CRS, New York, New York, United States

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 100

Registration Number: NCT00000904

Locations: 🇺🇸
UW - Seattle AVEG, Seattle, Washington, United States
🇺🇸
UAB AVEG, Birmingham, Alabama, United States
🇺🇸
St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States

and more 3 locations

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Phase 1

Completed

Conditions: HIV Infections
HIV Seronegativity

Interventions: Biological: Placebo version of rgp120/HIV-1MN
Biological: rgp120/HIV-1MN
Biological: rgp120/HIV-1 SF-2
Biological: Placebo version of rgp120/HIV-1SF2

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 156

Registration Number: NCT00000774

Locations: 🇺🇸
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States
🇺🇸
Chicago Children's CRS, Chicago, Illinois, United States
🇺🇸
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore, Maryland, United States

and more 34 locations

Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 16

Registration Number: NCT00000670

Locations: 🇺🇸
UCD Med Ctr, Sacramento, California, United States
🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States

Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 320

Registration Number: NCT00000678

Locations: 🇺🇸
Graduate Hosp, Philadelphia, Pennsylvania, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Davies Med Ctr, San Francisco, California, United States

and more 7 locations

Half-Dose Flu Vaccine Study in Healthy Adults

Phase 2

Completed

Conditions: Influenza

First Posted Date: 2001-08-31

Last Posted Date: 2010-08-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 840

Registration Number: NCT00006146

Locations: 🇺🇸
UCLA Center for Vaccine Research, Torrance, California, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Center for Vaccine Development, St Louis, Missouri, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy